Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
The typical denied patient: Female, age 38 to 52 BMI 32 to 41 Prediabetes (A1C 5.9% to 6.3%) or newly diagnosed type 2 diabetes (A1C 6.5% to 7.2%) Medicaid coverage through a state that requires A1C above 7.5% for GLP-1 approval Tried metformin for 60 to 90 days with partial response (A1C dropped from 7.0% to 6.7%, not enough to meet state threshold) Provider submitted PA, denied for "A1C not above threshold" The denial is technically correct under the state's criteria, but clinically frustrating
After 40 weeks of treatment, tirzepatide demonstrated significant reductions in HbA1c: -2.01% at 5 mg, -2.24% at 10 mg, and -2.30% at 15 mg
For a more detailed approach, platforms like Welling , Jurni GLP , or Lina use AI to uncover patterns in your data
Which habits help you stay consistent
A number of studies support the use of GLP-1 for weight loss
Contact TruLaw using the chat on this page to receive an instant case evaluation and determine if you qualify to file an NAION lawsuit today
US$ 21.46
US$ 24.70
US$ 27.91
US$ 27.13
US$ 25.34
